Skip to main content
FRANCE - AFRICA

French researchers develop quick Ebola diagnosis device

http://www.english.rfi.fr/general/20141020-classy-glassy-luxury-louis-vuitton-unveils-cultural-centre-entirely-glass
http://www.english.rfi.fr/general/20141020-classy-glassy-luxury-louis-vuitton-unveils-cultural-centre-entirely-glass Reuters/Michaela Rehle

The new tool, developed by France's Atomic Energy Commission, could allow doctors to diagnose a patient with suspected Ebola in under 15 minutes.

Advertising

France’s Atomic Energy Commission said that the device, which has undergone trials at a high-security for validating the technique and prototype, would be available in Ebola-hit countries by the end of October for a clinical trial.

It further added that the tool, not yet approved by regulators, works by monoclonal antibodies reacting to the presence of virus in a tiny sample, which can be a drop of blood, plasma or urine.

French pharmaceutical company Vedalab is turning the process into a user-friendly kit called Ebola eZYSCREEN.

Dossier: Ebola outbreak 2014

Similar to a DIY pregnancy test, a positive result sees a small stripe showing up in a results window on the hand-held device.

The kit is simple to use in the field without any additional equipment, said the CEA, which also does non-nuclear research with a possible military or security application.

"Current tests, which are based on genetic detection of the virus, are highly sensitive but need special equipment, take between two and a quarter and two and a half hours and can only be carried out in a lab," the commission explained.

Scientists at the agency began working on the diagnostic tool in mid-August, when the epidemic in Guinea, Liberia and Sierra Leone worsened.

The achievement builds on previous Ebola research funded in part by the French defence ministry as part of its anti-bioterrorism programme.

This research had "saved more than a year" in development time of the diagnostic test, the CEA said.

Other pharmaceutical teams are also working on fast diagnostic tools for Ebola.

They include Primerdesign, a spinoff company of Britain's University of Southampton, and Corgenix Medical Corp of the United States.

The test is for the so-called Zaire ebolavirus, the strain now circulating in West
Africa.
 

Daily news briefReceive essential international news every morning

Page not found

The content you requested does not exist or is not available anymore.